These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2403389)

  • 1. Aprophit: an irreversible antagonist for muscarinic receptors.
    Newman AH; Covington J; Oleshansky M; Jackson BW; Weissman BA; Leader H; Chiang PK
    Biochem Pharmacol; 1990 Sep; 40(6):1357-64. PubMed ID: 2403389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of muscarinic pharmacophores on the cholinergic regulation of catecholamine secretion from perfused adrenal glands.
    Nakazato Y; Oleshansky MA; Chiang PK
    Arch Int Pharmacodyn Ther; 1988; 293():209-18. PubMed ID: 3421778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of muscarine receptors of PC12 (rat phaeochromocytoma) cells.
    Bönisch H; Boer R; Dobler M; Schudt C
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):158-64. PubMed ID: 2342599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of in vitro actions with behavioral effects of antimuscarinic agents.
    Witkin JM; Gordon RK; Chiang PK
    J Pharmacol Exp Ther; 1987 Sep; 242(3):796-803. PubMed ID: 3498817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).
    Leader H; Gordon RK; Baumgold J; Boyd VL; Newman AH; Smejkal RM; Chiang PK
    J Med Chem; 1992 Apr; 35(7):1290-5. PubMed ID: 1560441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.
    Giraldo E; Micheletti R; Montagna E; Giachetti A; Viganò MA; Ladinsky H; Melchiorre C
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1016-20. PubMed ID: 3252019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]N-methylscopolamine dissociation from muscarine receptors affected by low concentrations of allosteric modulators.
    Christopoulos A; Mitchelson F
    Eur J Pharmacol; 1995 Aug; 290(3):259-62. PubMed ID: 7589221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological differentiation of presynaptic M1 muscarinic receptors modulating acetylcholine release from postsynaptic muscarinic receptors in guinea-pig ileum.
    Kawashima K; Fujimoto K; Suzuki T; Oohata H
    Gen Pharmacol; 1990; 21(1):17-21. PubMed ID: 2298386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent noncompetitive antagonism of muscarinic receptor mediated Ca2+ mobilization by some muscarinic antagonists.
    Kukkonen J; Akerman KE
    Biochem Biophys Res Commun; 1992 Dec; 189(2):919-24. PubMed ID: 1472064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD; Annis SJ; Ehlert FJ; Leslie FM
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular probes for muscarinic receptors: derivatives of the M1-antagonist telenzepine.
    Karton Y; Baumgold J; Handen JS; Jacobson KA
    Bioconjug Chem; 1992; 3(3):234-40. PubMed ID: 1520727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and muscarinic receptor binding profiles of antagonist benzotriazole derivatives.
    Cappello B; Greco G; Novellino E; Perissutti E; Santagada V; Silipo C; Vittoria A; Di Carlo R; Meli R; Muccioli G
    Farmaco; 1993 Jul; 48(7):907-18. PubMed ID: 8397675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective antagonism by pirenzepine and N-methyl-scopolamine on muscarinic receptor subtypes of the rat vas deferens.
    Miranda HF; Silva WI; Wolstenholme WW; Cuevas N
    Gen Pharmacol; 1988; 19(3):417-20. PubMed ID: 3417103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini.
    Korc M; Ackerman MS; Roeske WR
    J Pharmacol Exp Ther; 1987 Jan; 240(1):118-22. PubMed ID: 2433426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.